Spotlight Pathology 🇬🇧
AI digital pathology software for faster blood cancer diagnosis
About Spotlight Pathology
Spotlight develops AI-driven digital pathology tools designed to enhance the efficiency of clinical workflows, particularly in the diagnosis of blood cancers. Their technologies include automated sample classification, triage, and cell counting, which integrate with existing systems to reduce diagnostic turnaround times and improve overall clinical performance.
Spotlight Pathology is a UK-based company founded in 2021, now around 7 people. It has raised $1.8M in disclosed funding. FundFinder classes it as AI & ML.
Founder: Martin Fergie (Co-Founder and Chief Technology Officer; previously DigitalBridge HQ; University of Manchester).
Its investors also appear on FundFinder's most-active lists for Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds), Seed · Life Sciences (32 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · £1.4m · Mar 2026
- UK Innovation & Science Seed Fund (UKI2S) — Evergreen, government-backed pre-seed+ fund managed by Future Planet Capital. · cheques up to £1.5M